| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |